T2 Biosystems, Inc. (NASDAQ:TTOO) Q1 2022 Earnings Conference Call May 5, 2022 4:30 PM ET Company Participants Malcolm MacLeod - IR Philip Taylor - Gilmartin Group John Sperzel - Chairman and CEO John Sprague - CFO Brett Giffin - Chief Commercial Officer Conference Call Participants Benjamin Haynor - Alliance Global Partners Stephen Brozak - WBB Operator Good day, ladies and gentlemen, and welcome to the T2 Biosystems First Quarter 2022 Earnings Conference Call. At this time, all participants have been pla ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the year ended December 31, 2021 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-36571 T2 Biosystems, Inc. (Exact name of registrant as specified in its charter) | Delaware | 20-4827488 | | --- | --- | | (State or other jur ...

T2 Biosystems, Inc. (NASDAQ:TTOO) Q4 2021 Earnings Conference Call February 17, 2022 4:30 PM ET Company Participants Philip Taylor - Gilmartin Group John Sperzel - Chairman & CEO John Sprague - CFO Brett Giffin - Chief Commercial Officer Conference Call Participants Mark Massaro - BTIG Benjamin Haynor - Alliance Global Partners Stephen Brozak - WBB Securities Kyle Mikson - Canaccord Genuity Operator Hello, and welcome to the T2 Biosystems Fourth Quarter and Full Year 2021 Earnings Call and Webcast. [Operato ...

T2 Biosystems, Inc. (NASDAQ:TTOO) Q3 2021 Results Earnings Conference Call November 4, 2021 4:30 PM ET Company Participants Philip Taylor - Investor Relations. John Sperzel - Chairman & CEO John Sprague - CFO Conference Call Participants Operator Good afternoon, and welcome to the T2 Biosystems Third Quarter 2021 Earnings Conference Call. [Operator Instructions]. Please note, this event is being recorded. I would now like to turn the conference over to, Philip Taylor, Investor Relations. Please go ahead. Ph ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-36571 T2 Biosystems, Inc. (Exact name of registrant as specified in its charter) Delaware 20-4827488 (State or other jurisd ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-36571 T2 Biosystems, Inc. (Exact name of registrant as specified in its charter) Delaware 20-4827488 (State or other jurisdictio ...

T2 Biosystems, Inc. (NASDAQ:TTOO) Q2 2021 Earnings Conference Call August 5, 2021 4:30 PM ET Company Participants Greg Chodaczek - Managing Director, Gilmartin Group John Sperzel - Chairman & CEO John Sprague - CFO Conference Call Participants Operator Greetings, and welcome to the T2 Biosystems Second Quarter 2021 Earnings Conference Call. [Operator Instructions]. As a reminder, this conference is being recorded. I would now like to turn the conference over to your host, Greg Chodaczek, Managing Director o ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-36571 T2 Biosystems, Inc. (Exact name of registrant as specified in its charter) (I.R.S. Employer Identification No.) 101 Hartw ...

T2 Biosystems, Inc. (NASDAQ:TTOO) Q1 2021 Earnings Conference Call May 6, 2021 4:30 PM ET Company Participants Philip Taylor - Investor Relations, Gilmartin Group John Sperzel - President and Chief Executive Officer John Sprague - Chief Financial Officer Conference Call Participants Stephanie Yan - Canaccord Genuity Ben Haynor - Alliance Global Partners Operator Good day and welcome to the T2 Biosystems First Quarter 2021 Earnings Conference Call. Today's conference is being recorded. At this time, I would ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the year ended December 31, 2020 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-36571 T2 Biosystems, Inc. (Exact name of registrant as specified in its charter) Delaware 20-4827488 (State or other jurisdiction of incorpora ...